New findings suggest that a PSA level of 0.2 ng/mL or greater can predict a poor prognosis and indicate a possible need for ...

The thing that I worry about more than loss of exclusivity is this term that I introduced at the AACR meeting -- loss of relevancy" says Susan Galbraith, EVP of Oncology R&D at AstraZeneca.

AstraZeneca’s share price has fallen a lot from its September high, but this could mean a tremendous opportunity for me to ...

Understand every aspect of the global economy – and know how to make your next move.

During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with ...

An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...

Soros Fund Management's 13F portfolio grew slightly to $6.70B in Q1 2025. Check out the significant new stakes and major ...

Databricks, the Data and AI company, today introduced Agent Bricks, a new, automated way to create high-performing AI agents ...

Urgent government calls for more high-powered sovereign computers to fulfil Swedish goal of building a more powerful AI ...

In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...

The main news piece as of late was Nvidia CEO Jensen Huang's comments at GTC Paris, stating that "quantum computing is ...

At the Data + AI Summit, Databricks announced the launch of Agent Bricks, a new offering that allows businesses to build and ...